RxDoctor Payments DataLook up a doctor →

Brent Grass, APRN

Adult Health · Massillon, OHNPI 1295353183

Payments from drug & device makers

$11,663in general payments, 2019–2025

Across 803 payments — averaging $14.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$2K
  • AstraZeneca$1K
  • GSK$738
  • Pfizer$673
  • Lilly USA, LLC$668
  • plus $4K from 41 others

What the payments were for

  • Food & beverage$11,57399%
  • Education$901%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,663 in reported general payments places this provider in the 95th percentile of 1,184 adult health providers in Ohio.

See all adult health providers in Ohio

Medicare billing

Part B allowed, 2024
$38,511
Medicare patients
177
Services billed
572

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin93$93,756
Trelegy ElliptaFluticasone/Umeclidin/Vilanter64$72,444
EliquisApixaban40$49,302
OzempicSemaglutide34$36,051
JanuviaSitagliptin Phosphate17$23,565
FarxigaDapagliflozin Propanediol17$16,761
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog17$16,564
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$14,786
TradjentaLinagliptin13$10,821
Repatha SureclickEvolocumab11$5,935
Albuterol Sulfate HfaAlbuterol Sulfate133$4,537
Atorvastatin Calcium495$3,686
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$3,008
Testosterone15$2,922
Gabapentin161$2,102

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$476$104,576106 claims
GSKTrelegy Ellipta$738$72,44464 claims
PfizerEliquis$673$49,30240 claims
Novo NordiskOzempic$1,703$36,05134 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,382$31,54634 claims
MerckJanuvia$246$23,56517 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,184 adult health providers in Ohio.

Other adult health in Massillon

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →